Merck & Co. (MRK)
(Delayed Data from NYSE)
$93.13 USD
+1.13 (1.23%)
Updated Jun 24, 2022 04:06 PM ET
3-Hold of 5 3
B Value A Growth B Momentum A VGM
Balance Sheet
Fiscal Year End for Merck & Co, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 8,096 | 8,062 | 10,450 | 8,864 | 8,498 |
Receivables | 9,230 | 7,851 | 6,778 | 7,071 | 6,873 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 5,953 | 6,310 | 5,978 | 5,440 | 5,096 |
Other Current Assets | 6,987 | 5,541 | 4,277 | 4,500 | 4,299 |
Total Current Assets | 30,266 | 27,764 | 27,483 | 25,875 | 24,766 |
Net Property & Equipment | 19,279 | 17,986 | 15,053 | 13,291 | 12,439 |
Investments & Advances | 370 | 785 | 1,469 | 6,233 | 12,125 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 44,197 | 34,842 | 33,621 | 29,684 | 32,467 |
Deposits & Other Assets | 11,582 | 10,211 | 6,771 | 7,554 | 6,075 |
Total Assets | 105,694 | 91,588 | 84,397 | 82,637 | 87,872 |
Liabilities & Shareholders Equity | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 |
---|---|---|---|---|---|
Notes Payable | 2,412 | 6,431 | 3,610 | 5,308 | 3,057 |
Accounts Payable | 4,609 | 4,594 | 3,738 | 3,318 | 3,102 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 13,859 | 13,053 | 12,549 | 10,151 | 10,427 |
Income Taxes Payable | 1,224 | 1,575 | 736 | 1,971 | 708 |
Other Current Liabilities | 1,768 | 1,674 | 1,587 | 1,458 | 1,320 |
Total Current Liabilities | 23,872 | 27,327 | 22,220 | 22,206 | 18,614 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 3,441 | 1,015 | 1,470 | 1,702 | 2,219 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 30,690 | 25,360 | 22,736 | 19,806 | 21,353 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 9,434 | 12,482 | 11,970 | 12,041 | 11,117 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 67,437 | 66,184 | 58,396 | 55,755 | 53,303 |
Shareholders Equity | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1,788 | 1,788 | 1,788 | 1,788 | 1,788 |
Capital Surplus | 44,238 | 39,588 | 39,660 | 38,808 | 39,902 |
Retained Earnings | 53,696 | 47,362 | 46,602 | 42,579 | 41,350 |
Other Equity | -4,356 | -6,547 | -6,099 | -5,364 | -4,677 |
Treasury Stock | 57,109 | 56,787 | 55,950 | 50,929 | 43,794 |
Total Shareholder's Equity | 38,257 | 25,404 | 26,001 | 26,882 | 34,569 |
Total Liabilities & Shareholder's Equity | 105,694 | 91,588 | 84,397 | 82,637 | 87,872 |
Total Common Equity | 38,257 | 25,404 | 26,001 | 26,882 | 34,569 |
Shares Outstanding | 2,527.60 | 2,530.00 | 2,545.90 | 2,600.30 | 2,724.40 |
Book Value Per Share | 15.14 | 10.04 | 10.21 | 10.34 | 12.69 |
Fiscal Year End for Merck & Co, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2022 | 12/31/2021 | 9/30/2021 | 6/30/2021 | 3/31/2021 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 8,928 | 8,096 | 10,016 | 8,575 | 6,981 |
Receivables | 9,828 | 9,230 | 8,571 | 7,843 | 8,235 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 5,774 | 5,953 | 5,603 | 5,499 | 6,402 |
Other Current Assets | 6,654 | 6,987 | 6,868 | 6,748 | 5,291 |
Total Current Assets | 31,184 | 30,266 | 31,058 | 28,665 | 26,909 |
Net Property & Equipment | 19,747 | 19,279 | 18,565 | 18,064 | 18,295 |
Investments & Advances | 316 | 370 | 435 | 411 | 544 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 44,280 | 44,197 | 32,246 | 32,495 | 34,613 |
Deposits & Other Assets | 11,141 | 11,582 | 11,190 | 11,053 | 10,486 |
Total Assets | 106,668 | 105,694 | 93,494 | 90,688 | 90,847 |
Liabilities & Shareholders Equity | 3/31/2022 | 12/31/2021 | 9/30/2021 | 6/30/2021 | 3/31/2021 |
---|---|---|---|---|---|
Notes Payable | 1,208 | 2,412 | 3,534 | 2,488 | 7,251 |
Accounts Payable | 3,715 | 4,609 | 3,366 | 3,897 | 4,034 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 14,051 | 13,859 | 14,214 | 12,888 | 11,911 |
Income Taxes Payable | 1,571 | 1,224 | 954 | 971 | 1,490 |
Other Current Liabilities | 1,771 | 1,768 | 1,660 | 1,662 | 1,675 |
Total Current Liabilities | 22,316 | 23,872 | 23,728 | 21,906 | 26,361 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 3,071 | 3,441 | 1,527 | 1,489 | 1,204 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 30,586 | 30,690 | 22,907 | 24,033 | 24,002 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 9,742 | 9,469 | 9,872 | 12,241 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 65,715 | 67,437 | 57,631 | 57,300 | 63,808 |
Shareholders Equity | 3/31/2022 | 12/31/2021 | 9/30/2021 | 6/30/2021 | 3/31/2021 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1,788 | 1,788 | 1,788 | 1,788 | 1,788 |
Capital Surplus | 44,275 | 44,238 | 44,149 | 44,039 | 39,613 |
Retained Earnings | 56,252 | 53,696 | 51,691 | 48,777 | 48,888 |
Other Equity | -4,299 | -4,356 | -4,521 | -4,534 | -6,528 |
Treasury Stock | 57,063 | 57,109 | 57,244 | 56,682 | 56,722 |
Total Shareholder's Equity | 40,953 | 38,257 | 35,863 | 33,388 | 27,039 |
Total Liabilities & Shareholder's Equity | 106,668 | 105,694 | 93,494 | 90,688 | 90,847 |
Total Common Equity | 40,953 | 38,257 | 35,863 | 33,388 | 27,039 |
Shares Outstanding | 2,527.80 | 2,527.60 | 2,531.30 | 2,532.00 | 2,530.30 |
Book Value Per Share | 16.20 | 15.14 | 14.17 | 13.19 | 10.69 |